284 related articles for article (PubMed ID: 18663023)
1. R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.
Skripkin E; McConnell TS; DeVito J; Lawrence L; Ippolito JA; Duffy EM; Sutcliffe J; Franceschi F
Antimicrob Agents Chemother; 2008 Oct; 52(10):3550-7. PubMed ID: 18663023
[TBL] [Abstract][Full Text] [Related]
2. Resistance to linezolid caused by modifications at its binding site on the ribosome.
Long KS; Vester B
Antimicrob Agents Chemother; 2012 Feb; 56(2):603-12. PubMed ID: 22143525
[TBL] [Abstract][Full Text] [Related]
3. Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action.
Xiong L; Kloss P; Douthwaite S; Andersen NM; Swaney S; Shinabarger DL; Mankin AS
J Bacteriol; 2000 Oct; 182(19):5325-31. PubMed ID: 10986233
[TBL] [Abstract][Full Text] [Related]
4. Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations.
Sander P; Belova L; Kidan YG; Pfister P; Mankin AS; Böttger EC
Mol Microbiol; 2002 Dec; 46(5):1295-304. PubMed ID: 12453216
[TBL] [Abstract][Full Text] [Related]
5. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
Locke JB; Hilgers M; Shaw KJ
Antimicrob Agents Chemother; 2009 Dec; 53(12):5265-74. PubMed ID: 19752277
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
Shaw KJ; Poppe S; Schaadt R; Brown-Driver V; Finn J; Pillar CM; Shinabarger D; Zurenko G
Antimicrob Agents Chemother; 2008 Dec; 52(12):4442-7. PubMed ID: 18838596
[TBL] [Abstract][Full Text] [Related]
7. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria.
Swaney SM; Aoki H; Ganoza MC; Shinabarger DL
Antimicrob Agents Chemother; 1998 Dec; 42(12):3251-5. PubMed ID: 9835522
[TBL] [Abstract][Full Text] [Related]
8. Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci.
Livermore DM; Mushtaq S; Warner M; Woodford N
J Antimicrob Chemother; 2009 Apr; 63(4):713-5. PubMed ID: 19164418
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations.
Locke JB; Finn J; Hilgers M; Morales G; Rahawi S; G C K; Picazo JJ; Im W; Shaw KJ; Stein JL
Antimicrob Agents Chemother; 2010 Dec; 54(12):5337-43. PubMed ID: 20837751
[TBL] [Abstract][Full Text] [Related]
10. Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.
Locke JB; Hilgers M; Shaw KJ
Antimicrob Agents Chemother; 2009 Dec; 53(12):5275-8. PubMed ID: 19805557
[TBL] [Abstract][Full Text] [Related]
11. Oxazolidinone antibiotics target the P site on Escherichia coli ribosomes.
Aoki H; Ke L; Poppe SM; Poel TJ; Weaver EA; Gadwood RC; Thomas RC; Shinabarger DL; Ganoza MC
Antimicrob Agents Chemother; 2002 Apr; 46(4):1080-5. PubMed ID: 11897593
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid.
Toh SM; Xiong L; Arias CA; Villegas MV; Lolans K; Quinn J; Mankin AS
Mol Microbiol; 2007 Jun; 64(6):1506-14. PubMed ID: 17555436
[TBL] [Abstract][Full Text] [Related]
13. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
Pillai SK; Sakoulas G; Wennersten C; Eliopoulos GM; Moellering RC; Ferraro MJ; Gold HS
J Infect Dis; 2002 Dec; 186(11):1603-7. PubMed ID: 12447736
[TBL] [Abstract][Full Text] [Related]
14. New potent antibacterials against Gram-positive multiresistant pathogens: effects of side chain modification and chirality in linezolid-like 1,2,4-oxadiazoles.
Fortuna CG; Berardozzi R; Bonaccorso C; Caltabiano G; Di Bari L; Goracci L; Guarcello A; Pace A; Palumbo Piccionello A; Pescitelli G; Pierro P; Lonati E; Bulbarelli A; Cocuzza CE; Musumarra G; Musumeci R
Bioorg Med Chem; 2014 Dec; 22(24):6814-25. PubMed ID: 25464880
[TBL] [Abstract][Full Text] [Related]
15. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
Tsakris A; Pillai SK; Gold HS; Thauvin-Eliopoulos C; Venkataraman L; Wennersten C; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 2007 Sep; 60(3):649-51. PubMed ID: 17623697
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for context-specific inhibition of translation by oxazolidinone antibiotics.
Tsai K; Stojković V; Lee DJ; Young ID; Szal T; Klepacki D; Vázquez-Laslop N; Mankin AS; Fraser JS; Fujimori DG
Nat Struct Mol Biol; 2022 Feb; 29(2):162-171. PubMed ID: 35165456
[TBL] [Abstract][Full Text] [Related]
17. Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances.
Besier S; Ludwig A; Zander J; Brade V; Wichelhaus TA
Antimicrob Agents Chemother; 2008 Apr; 52(4):1570-2. PubMed ID: 18212098
[TBL] [Abstract][Full Text] [Related]
18. [Ribosomal antibiotics].
Man'kin AS
Mol Biol (Mosk); 2001; 35(4):597-609. PubMed ID: 11524946
[TBL] [Abstract][Full Text] [Related]
19. Ribosomes from an oxazolidinone-resistant mutant confer resistance to eperezolid in a Staphylococcus aureus cell-free transcription-translation assay.
Murray RW; Schaadt RD; Zurenko GE; Marotti KR
Antimicrob Agents Chemother; 1998 Apr; 42(4):947-50. PubMed ID: 9559817
[TBL] [Abstract][Full Text] [Related]
20. Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.
Jones RN; Ross JE; Bell JM; Utsuki U; Fumiaki I; Kobayashi I; Turnidge JD
Diagn Microbiol Infect Dis; 2009 Dec; 65(4):404-13. PubMed ID: 19913683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
